US$25 million financing

MacroGenics, Inc.

Our attorneys represented MacroGenics, Inc., a privately held biotechnology company based in Rockville, Maryland, in a US$25 million private financing round. MacroGenics expects to use the proceeds from this financing to fund the cancer stem cell program it acquired through its acquisition of Raven biotechnologies, inc. in July 2008, in addition to further advancing MacroGenics' autoimmune, cancer and infectious disease product candidate portfolio, as well as for general working capital purposes. (Our attorneys were MacroGenics' sole outside counsel in the Raven biotechnologies transaction.)

Email Disclaimer